The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
NeuroRx has been granted IND permission to test RLF-100 for inhaled use in patients with moderate and severe COVID-19 in order to prevent progression ...
read more
Wednesday, August 12, 2020
PTC announced the FDA has approved Evrysdi for spinal muscular atrophy in adults and children 2 months and older.
read more
Wednesday, August 12, 2020
Precigen ActoBio has met the primary endpoint assessing safety and tolerability in the monotherapy portion of the ongoing study investigating AG019 ...
read more
Wednesday, August 12, 2020
Enlivex announced the first patient has been dosed in an investigator-initiated multi-center clinical trial of AllocetraTM in COVID-19 patients with ...
read more
Thursday, August 13, 2020
The FDA approved Olinvyk, an opioid agonist for moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous ...
read more
Thursday, August 13, 2020
Seelos received notice from the FDA that the company may proceed with initiating a trial studying SLS-005 for the treatment of ALS.
read more
Thursday, August 13, 2020
Clearside Biomedical announced the FDA has accepted its IND application for CLS-AX, for CLS-AX in wet AMD patients by the end of 2020.
read more
Thursday, August 13, 2020
Protalix BioTherapeutics together with Chiesi Global Rare Diseases announced the FDA has accepted the BLA and granted Priority Review designation for ...
read more
Verrica has entered into an exclusive worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic ...
read more
Romark announced the initiation of a Phase 3 clinical trial of its investigational new drug candidate NT-300 as a treatment for mild or moderate COVID...
read more
Regeneron announced the FDA has accepted for Priority Review a BLA for evinacumab as an adjunct to other lipid-lowering therapies in patients with ...
read more
Boehringer Ingelheim announced the first patient has enrolled in a trial assessing nintedanib in children and adolescents with fibrosing interstitial ...
read more
Vaccibody and Nektar announced the first patient has been dosed in the study evaluating bempegaldesleukin with VB10.NEO.
read more
Kineta announced the CTA approval in the Netherlands for initiation of a first in-human clinical trial of KCP506.
read more
Kaiser Permanente has begun participating in a phase 3 clinical trial to test an investigational vaccine against SARS-CoV-2, the virus causing the ...
read more